[1]
H. Fayez, “Balancing benefit and burden: treatment intensification in paediatric KMT2A rearrangements acute myeloid leukaemia: KMT2A Rearrangements in Pediatric Intermediate-Risk Acute Myeloid Leukemia”, AO, vol. 64, pp. 1227–1236, Sep. 2025.